TAVR for all-Is it time?

Affiliations

Comment

Usman Mustafa et al. Catheter Cardiovasc Interv. 2023 May.

. 2023 May;101(6):1174-1175.

doi: 10.1002/ccd.30665. Epub 2023 Apr 25.

¹ Division of Cardiovascular disease, Ochsner LSU Health Science Center, Shreveport, Louisiana, USA.

No abstract available

Keywords: Aortic Valve Stenosis; Sustained Gradient; TAVR.

Comment on

Long-term durability of self-expanding and balloon-expandable transcatheter aortic valve prostheses: UK TAVI registry.
Ali N, Hildick-Smith D, Parker J, Malkin CJ, Cunnington MS, Gurung S, Mailey J, MacCarthy PA, Bharucha A, Brecker SJ, Hoole SP, Dorman S, Doshi SN, Wiper A, Buch MH, Banning AP, Spence MS, Blackman DJ. Ali N, et al. Catheter Cardiovasc Interv. 2023 Apr;101(5):932-942. doi: 10.1002/ccd.30627. Epub 2023 Mar 15. Catheter Cardiovasc Interv. 2023. PMID: 36924015

1. Ali N, Hildick-Smith D, Parker J, et al. Long-term durability of self-expanding and balloon-expandable transcatheter aortic valve prostheses: UK TAVI registry. Catheter Cardiovasc Interv. 2023;101(5):932-942. doi:10.1002/ccd.30627
1. Otto CM, Nishimura RA, Bonow RO, et al. 2020 ACC/AHA guideline for the management of patients with valvular heart disease: executive summary: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2020;143(5):e35-e71.
1. Jørgensen TH, Thyregod HGH, Ihlemann N, et al. Eight-year outcomes for patients with aortic valve stenosis at low surgical risk randomized to transcatheter vs. surgical aortic valve replacement. Eur Heart J. 2021;42(30):2912-2919.
1. Makkar RR, Thourani VH, Mack MJ, et al. Five-year outcomes of transcatheter or surgical aortic-valve replacement. N Engl J Med. 2020;382(9):799-809.
1. O'Hair D, Yakubov SJ, Grubb KJ, et al. Structural valve deterioration after self-expanding transcatheter or surgical aortic valve implantation in patients at intermediate or high risk. JAMA Cardiology. 2023;8(2):111-119.